1 | Sample | Range | 21-Jun-2012 | 10-Jan-2013 | 10-Oct-2013 | 14-Feb-2014 | 1-Apr-2014 | 12-Aug-2014 | 10-Dec-2014 | 27-Nov-2015 | |
---|---|---|---|---|---|---|---|---|---|---|---|
2 | WBC | Serum | 3,800 - 10,700 | 4,410 | 5,320 | 3,990 | 4,090 | 3,830 | 3,630 | 3,750 | 4310 |
3 | Eosinophil Absolute | Serum | 0 - 430 | 180 | 330 | 260 | 240 | 230 | 230 | 210 | |
4 | Eosinophil % | Serum | 0 - 5 % | 4% | 6% | 6% | 6% | 6 | 6% | 6% | |
5 | Neutrophil Absolute | Serum | 2,000 - 7,000 | 2,480 | 2,430 | 1,730 | 1,980 | 1,940 | 1,800 | ||
6 | Neutrophil % | Serum | 35 -74% | 56% | 46% | 44% | 48% | 51% | 48% | ||
7 | Lymphocites Absolute | Serum | 1,000 - 3,600 | 1,579 | 2,332 | 1,716 | 1,583 | 1,386 | 1,234 | 1,511 | 1,599 |
8 | Lymphocites % | Serum | 15.5 - 50 % | 36% | 44% | 43% | 39% | 36% | 34% | 40% | 37% |
9 | CD3 Absolute | Serum | 672 - 2,322 | 1,045 | 836 | 920 | 881 | ||||
10 | CD3 % | Serum | 57 - 86 % | 61% | 60% | 61% | 55% | ||||
11 | CD4 Absolute | Serum | 393 - 1,490 | 669 | 514 | 615 | 571 | ||||
12 | CD4 % | Serum | 30 - 60 % | 39% | 37% | 41% | 36% | ||||
13 | CD8 Absolute | Serum | 197 - 993 | 305 | 223 | 255 | 255 | ||||
14 | CD8 % | Serum | 13 - 40 | 18% | 16% | 17% | 16% | ||||
15 | CD19 Absolute | Serum | 100 - 430 | 240 | 247 | 310 | 310 | ||||
16 | CD19% | Serum | 6 - 23 | 14% | 18% | 21% | 21% | ||||
17 | CD4/CD8 ratio | Serum | 1.0 - 3.6 | 2.19 | 2.30 | 2.41 | 2.24 | ||||
18 |
1 | Sample | 14-Mar-2012 | 11-Apr-2012 | 29-Jun-2012 | 20-Sep-2012 | 31-Oct-2012 | 30-Aug-2013 | 25-Nov-2013 | 9-Apr-2014 | 24-Apr-2014 | 13-Jan-2015 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | anti HIV 1/2 + p24 (Vironostika Uniform II) | Serum | Negative | Negative | Negative | Negative | |||||||
3 | anti HIV 1/2 + p24 (Abbott Architect) | Serum | Negative | ||||||||||
4 | anti HIV 1/2 + p24 | Serum | Negative | Negative | |||||||||
5 | HIV-1 PCR RNA | Serum | Negative | ||||||||||
6 | |||||||||||||
7 | anti-HSV 1/2 IgM Elisa | Serum | Negative | ||||||||||
8 | anti-HSV 1/2 IgG Elisa | Serum | Positive | ||||||||||
9 | HSV-1 DNA (PCR) | Serum | Negative | ||||||||||
10 | HSV-2 DNA (PCR) | Serum | Negative | ||||||||||
11 | |||||||||||||
12 | anti EBV (VCA) IgM Elisa | Serum | Negative | Negative | |||||||||
13 | anti EBV (VCA) IgG Elisa | Serum | Positive | Positive | |||||||||
14 | anti EBV (EBNA-1) IgG Elisa | Serum | Positive | Positive | |||||||||
15 | |||||||||||||
16 | anti-HAV IgM CMIA | Serum | Negative | ||||||||||
17 | anti-HAV total CMIA | Serum | Positive | ||||||||||
18 | HBsAg (CMIA) | Serum | Negative | Negative | |||||||||
19 | anti-HCV (CMIA) | Serum | Negative | Negative | Negative | ||||||||
20 | |||||||||||||
21 | anti-CMV IgM Elisa | Serum | Negative | ||||||||||
22 | anti-CMV IgG Elisa | Serum | Positive | ||||||||||
23 | HPV-16 (unknown method) | Oral swab | Positive | Negative | |||||||||
24 | anti-HTLV 1/2 Elisa | Serum | Negative | ||||||||||
25 |
1 | Date | 21-Dec-2010 | 21-Jun-2012 | 17-Aug-2012 | 10-Jan-2013 | 1-Feb-2013 | 10-Oct-2013 | 18-Dec-2013 | 14-Feb-2014 | Range reference | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | GMT | 3.04 | 4.4 | 1.56 | 4.76 | 2.98 | 2.75 | 5.05 | 2.43 | 0.00-1.13 | ||
3 | ALT | 0.56 | 0.94 | 0.73 | 1.81 | 0.78 | 1.09 | 1.38 | 0.67 | 0.15-0.95 | ||
4 | AST | 0.44 | 0.59 | 0.59 | 0.96 | 0.5 | 0.96 | 0.94 | 0.6 | 0.20-0.71 | ||
5 |
1 | Date | Range reference | 18-Dec-2013 | ||
---|---|---|---|---|---|
2 | S-TSH | 0.35 - 5.10 | 1.73 | ||
3 | S-T4 | 10.50 - 22.70 | 19.24 | ||
4 | S-anti TG | 0 - 1 | 0.2 | ||
5 | S-anti PO | 0 - 1 | 0.36 | ||
6 | S-LH | 1.21 - 11.48 | 2.5 | ||
7 | S-FSH | 1 - 19.08 | 1.58 | ||
8 | S-Prolactin | 2.10 - 17.70 | 14.6 | ||
9 | S-Testosteron | 7.96 - 27.3 | 19.8 | ||
10 | S-Cortisol AM Test | 118.6 - 618.0 | 295.9 | ||
11 | S-CRP | 0 - 5 | 0.4 | ||
12 |
1 | Test | Detail | 26-Sep-2013 | 4-Apr-2014 | |
---|---|---|---|---|---|
2 | AMA | Antimitochondrial Antibodies | Negative | Negative | |
3 | HMA | Antibodies to the hepatocyte membrane | Negative | ||
4 | ABKA | Negative | |||
5 | ANA-Hep2 | Negative | Negative | ||
6 | ENA | Negative | |||
7 | anti-nRNP/SM | Negative | |||
8 | anti-Sm | Negative | |||
9 | anti-SS-A | Negative | |||
10 | anti-Ro-52 | Negative | Negative | ||
11 | anti-SS-B | Negative | |||
12 | anti-Scl-70 | Negative | |||
13 | anti-PM-Sck | Negative | |||
14 | anti-Jo-1 | Negative | |||
15 | anti-CENP B | Negative | |||
16 | anti-PCNA | Negative | |||
17 | anti-DSdna | Negative | |||
18 | anti-nucleosome | Negative | |||
19 | anti-histone | Negative | |||
20 | anti-Rib-P | Negative | |||
21 | AMA-M2 | Negative | Negative | ||
22 | anti-ME-3E (BPO) | Negative | |||
23 | anti-SP 100 | Negative | |||
24 | anti-PML | Negative | |||
25 | anti-gp 210 | Negative | |||
26 | anti-LKM-1 | Negative | |||
27 | anti-LC-1 | Negative | |||
28 | anti-SLA/LP | Negative | |||
29 |
1 | Sample | 9-Oct-2012 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | Borrelia burg. IgM (ELISA) | Serum | Negative | |||||||||
3 | Borrelia burg. IgG (ELISA) | Serum | Negative | |||||||||
4 | Chl.pneumoniae IgA (ELISA) | Serum | Negative | |||||||||
5 | Chl.pneumoniae IgG (ELISA) | Serum | Negative | |||||||||
6 | M.pneumoniae IgM (ELISA) | Serum | Negative | |||||||||
7 | M.pneumoniae IgG (ELISA) | Serum | Positive | |||||||||
8 | anti H.pylori IgG (ELISA) | Serum | Negative | |||||||||
9 | ||||||||||||
10 | ||||||||||||
11 | ||||||||||||
12 | ||||||||||||
13 | ||||||||||||
14 | ||||||||||||
15 | ||||||||||||
16 | ||||||||||||
17 | ||||||||||||
18 |
1 | Sample | 9-Oct-2012 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | Toxoplasma IgG - ELISA | Serum | Negative | |||||||||
3 | Toxoplasma IgM - ELISA | Serum | Negative | |||||||||
4 | Toxoplasma KFR | Serum | Negative | |||||||||
5 | ||||||||||||
6 | ||||||||||||
7 | ||||||||||||
8 | ||||||||||||
9 | ||||||||||||
10 | ||||||||||||
11 | ||||||||||||
12 | ||||||||||||
13 | ||||||||||||
14 | ||||||||||||
15 | ||||||||||||
16 | ||||||||||||
17 | ||||||||||||
18 |